PHKG2 and non-small cell lung carcinoma: The above results suggest that changes in PHKG2 expression do not significantly affect the viability and ferroptosis of NSCLC cells but can promote radiotherapy-induced ferroptosis in NSCLC cells, thereby increasing radiosensitivity and reversing radioresistance.